Final height after gonadotropin-releasing hormone agonists with or without growth hormone in Korean girls with central p
- PDF / 687,631 Bytes
- 1 Pages / 595.276 x 793.701 pts Page_size
- 43 Downloads / 182 Views
POSTER PRESENTATION
Open Access
Final height after gonadotropin-releasing hormone agonists with or without growth hormone in Korean girls with central precocious puberty and early puberty Eun Byul Kwon*, Young Suk Shim, Hae Sang Lee, Hwal Rim Jeong, Jin Soon Hwang From 8th APPES Biennial Scientific Meeting Darwin, Australia. 29 October – 1 November 2014 Aims We investigated the final height (FH) in GnRHa treatment with or without GH in Korean girls with CPP or EP. Methods The forty-one patients were divided retrospectively into three groups: group 1 subjects with CPP (n=20) received GnRHa. Group 2 with early puberty (n=12) received only GnRHa. Group 3 with early puberty (n=9) received combined treatment with GH and GnRHa. Results The mean age at the start of treatment was 8.11 ± 0.70 years in group 1, 8.98 ± 0.38 years in group 2 and 9.46 ± 0.46 years in group 3, respectively. The mean predicted adult height (PAH) SDS at the start of treatment was -1.29 ± 1.16 in group 1, -1.14 ± 0.88 in group 2 and -1.87 ± 1.09 in group 3, respectively. Rate of growth during treatment with GnRHa combined with GH was higher significantly in group 3 (6.89 ± 1.45 cm) than in group 1 (5.27 ± 0.89 cm, p = 0.001) and in group 2 (5.64 ± 0.72 cm, p = 0.022). The mean FH SDS was -0.60 ± 0.88 in group 1, -0.40 ± 1.03 in group 2 and -0.92 ± 0.72, respectively and significantly higher than initial height prediction. For the girls received GnRHa alone, FH SDS was correlated significantly with TH SDS, PAH at the start of treatment, PAH at the discontinuation of treatment.
Conclusion After GnRHa treatment in girls with CPP or EP, FH is significantly higher than initial height prediction. GnRHa treatment combined with GH resulted in higher growth rate. Published: 28 April 2015
doi:10.1186/1687-9856-2015-S1-P95 Cite this article as: Kwon et al.: Final height after gonadotropinreleasing hormone agonists with or without growth hormone in Korean girls with central precocious puberty and early puberty. International Journal of Pediatric Endocrinology 2015 2015(Suppl 1):P95.
Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color figure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution
Department of Pediatrics, Ajou University Hospital, School of Medicine, Ajou University, Suwon, Korea
Submit your manuscript at www.biomedcentral.com/submit
© 2015 Kwon et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Data Loading...
